Skip to content


Lonsurf (tipiracil) is a small molecule pharmaceutical. Tipiracil was first approved as Lonsurf on 2015-09-22. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. Lonsurf's patents are valid until 2037-02-03 (FDA).
Trade Name Lonsurf
Common Name Tipiracil
Indication colorectal neoplasms
Drug Class Uracil type antineoplastics
Get full access now